Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Aventis Pharma Limited, One Onslow StreetGuildford, Surrey, GU1 4YS, UK or trading as Sanofi-aventis or Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Nozinan 25mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. Circular, greyish-white cream, biconvex uncoated tablet. One face with Nozinan around a central 25 and a breakline on the reverse. |
Levomepromazine maleate 25mg per tablet.
For excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levomepromazine |
Levomepromazine resembles chlorpromazine and promethazine in the pattern of its pharmacology. It possesses anti-emetic, antihistamine and anti-adrenaline activity and exhibits a strong sedative effect. |
| List of Excipients |
|---|
|
Potato starch |
PVC/PVdC/aluminium foil blister pack containing 84 tablets.
OR
High density polyethylene bottle with flip cap or polypropylene tablet container.
Each pack contains 500 tablets.
Not all pack sizes may be marketed.
Aventis Pharma Limited, One Onslow StreetGuildford, Surrey, GU1 4YS, UK
or trading as
Sanofi-aventis or Sanofi, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
PL 04425/0658
19th June 2009
| Drug | Countries | |
|---|---|---|
| NOZINAN | Austria, Canada, Estonia, France, Croatia, Ireland, Malta, Netherlands, New Zealand, Tunisia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
